Free Trial

Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of "Moderate Buy" from Brokerages

Privia Health Group logo with Medical background

Key Points

  • Privia Health Group, Inc. has received an average rating of "Moderate Buy" from 15 analysts, with 12 buy, 2 hold, and 1 sell recommendations.
  • The average price target set by analysts over the past year is $28.42, although some analysts have varied their targets based on recent evaluations.
  • Institutional investors own approximately 94.48% of Privia Health Group's stock, with significant increases in holdings from firms like CWM LLC and Bessemer Group Inc.
  • Five stocks to consider instead of Privia Health Group.

Shares of Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the fifteen ratings firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and twelve have assigned a buy recommendation to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $28.4167.

A number of equities research analysts recently weighed in on the company. Evercore ISI dropped their price target on Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 9th. Stephens reaffirmed an "overweight" rating and set a $32.00 price target on shares of Privia Health Group in a report on Wednesday, September 24th. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Privia Health Group in a report on Wednesday. Barclays raised their price target on Privia Health Group from $21.00 to $22.00 and gave the company an "equal weight" rating in a report on Thursday. Finally, Piper Sandler cut their price target on Privia Health Group from $36.00 to $35.00 and set an "overweight" rating for the company in a report on Monday, August 11th.

Get Our Latest Analysis on Privia Health Group

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. CWM LLC increased its position in Privia Health Group by 50.3% during the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock worth $40,000 after buying an additional 604 shares during the period. Bessemer Group Inc. increased its position in shares of Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock worth $51,000 after purchasing an additional 2,178 shares during the period. Russell Investments Group Ltd. increased its position in shares of Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after purchasing an additional 2,567 shares during the period. GAMMA Investing LLC increased its position in shares of Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock worth $75,000 after purchasing an additional 3,173 shares during the period. Institutional investors own 94.48% of the company's stock.

Privia Health Group Trading Down 1.3%

NASDAQ PRVA opened at $24.20 on Friday. The company has a market cap of $2.97 billion, a PE ratio of 220.02, a PEG ratio of 3.35 and a beta of 0.83. Privia Health Group has a 12 month low of $16.47 and a 12 month high of $26.09. The stock has a 50 day moving average of $22.36 and a 200-day moving average of $22.45.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last released its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The company had revenue of $213.61 million during the quarter. Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%. As a group, sell-side analysts predict that Privia Health Group will post 0.14 EPS for the current fiscal year.

About Privia Health Group

(Get Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Further Reading

Analyst Recommendations for Privia Health Group (NASDAQ:PRVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Privia Health Group Right Now?

Before you consider Privia Health Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.

While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.